MNOV Latest Press Releases

-- May 26, 2026 --

MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast) Globe Newswire 7:00 PM

-- April 27, 2026 --

New Peer-Reviewed Study Reveals Actionable Immune-Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation Globe Newswire 7:00 PM

-- March 16, 2026 --

MediciNova to Participate at the 38th Annual ROTH Conference Globe Newswire 7:00 AM

-- January 29, 2026 --

MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN-166 (ibudilast) in ALS patients Globe Newswire 6:00 PM

-- January 6, 2026 --

2026 New Year's Greetings from the CEO Globe Newswire 9:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software